SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Of Kayak Software Corporation (KYAK), First California Financial Group, Inc. (FCAL), Metropolitan Health Networks, Inc. (MDF) And DUSA Pharmaceuticals Inc. (DUSA)
NEW YORK, Nov. 9, 2012 /PRNewswire/ --
Kayak Software CorporationLevi & Korsinsky is investigating the Board of Directors of Kayak Software Corporation (NasdaqGS: KYAK) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to priceline.com Incorporated (NasdaqGS: PCLN) under which shareholders would receive cash and stock valued at approximately $40 per share.
Click here to learn more about the investigation: http://zlk.9nl.com/kayak-software-kyak , or call: 877-363-5972.
(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO)
First California Financial Group, Inc.Levi & Korsinsky is investigating the Board of Directors of First California Financial Group, Inc. (Nasdaq: FCAL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to PacWest Bancorp (Nasdaq: PACW) for stock valued at approximately $8 per share. Click here to learn more about the investigation: http://zlk.9nl.com/first-california-financial-fcal , or call: 877-363-5972. Metropolitan Health Networks, Inc.Levi & Korsinsky is investigating the Board of Directors of Metropolitan Health Networks, Inc. (NYSE: MDF) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Humana Inc. (NYSE: HUM) for $11.25 per share. At least one analyst set a price target for Metropolitan stock at $13.00 per share. Click here to learn more about the investigation: http://zlk.9nl.com/metropolitan-health-networks-mdf , or call: 877-363-5972. DUSA Pharmaceuticals Inc.Levi & Korsinsky is investigating the Board of Directors of DUSA Pharmaceuticals Inc. (Nasdaq: DUSA) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Sun Pharmaceutical Industries Limited (Reuters: SUN.BO) for $8 per share. Click here to learn more about the investigation: http://zlk.9nl.com/dusa-pharmaceuticals-dusa , or call: 877-363-5972. Levi & Korsinsky is a national firm with offices in New York and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes. CONTACT:Levi & Korsinsky, LLP Joseph Levi, Esq. Eduard Korsinsky, Esq.30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500Toll Free: (877) 363-5972Fax: (212) 363-7171 www.zlk.com SOURCE Levi & Korsinsky, LLP
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
